Merck Sales Slide On Expiring Drug Patents But Shares Lifted By Cancer-Fighting Collaboration

Pharmaceutical company Merck saw a decline in fourth quarter profit and revenue thanks to patent expirations, but shares of the company are rising on the news that the drugmaker has agreed to three different partnerships to test cancer treatments.